Effect of Fetal Aortic Valvuloplasty on Outcomes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age23-31
SponsorQueen Silvia Children's Hospital, Gothenburg, Sweden

About this trial

In one of the most severe congenital heart defects, hypoplastic left heart syndrome (HLHS), the left ventricle is underdeveloped and the prognosis is worse than in most other heart defects. The underdevelopment can occur gradually during fetal growth caused by a narrowing of the aortic valve. At some international centers, such fetuses are treated with a balloon dilation of the narrowed valve, but there is no scientifically sound evidence that this treatment is effective.

The aim of this study is: 1/ to evaluate whether balloon dilation during the fetal period of a narrowed aortic valve can reduce the risk of the left ventricle becoming underdeveloped and the baby being born with a so-called univentricular heart (HLHS); 2/ to investigate whether such treatment improves the prognosis for this group of children with a very complex and severe heart defect and 3/ to also describe side effects and risks in fetuses and mothers of the fetal procedure.

Eligibility criteria

Qualifiers

Aortic valve stenosis with antegrade flow through the valve

Predominantly left-to-right shunt at the atrial level

Predominantly retrograde flow in the aortic arch between the first two brachiocephalic vessels

Qualitatively depressed left ventricular function

Disqualifiers

Any associated cardiac defect except persistent left superior vena cava and coarctation of the aorta

Any significant (i.e. that might influence outcome) extracardiac anomaly and/or known chromosomal aberration. Also, if such a condition is present at inclusion but diagnosed only after birth the case will be retrospectively excluded.

Trial design

Treatments tested in this trial

  • Fetal aortic balloon dilatation

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Queen Silvia Children's Hospital, Gothenburg, Sweden

Lead sponsor

Swedish Heart Lung Foundation

Collaborator

Sahlgrenska University Hospital

Collaborator